P

Inventor

OTTOW ECKHARD

DE39 patents
⚠️ This page may combine multiple inventors who share the name “OTTOW ECKHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

32 patents
US5089488AFeb 18, 1992

β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same

SCHERING AG44 citations96
US4814327AMar 21, 1989

11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same

SCHERING AG49 citations96
US6025376AFeb 15, 2000

Chiral methylphenyloxazolidinones

SCHERING AG32 citations92
US5843931ADec 1, 1998

6,7-modified 11β-aryl-4-oestrenes

SCHERING AG21 citations92
US5843933ADec 1, 1998

11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

SCHERING AG31 citations92
US5728689AMar 17, 1998

11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

SCHERING AG18 citations92
US5446036AAug 29, 1995

13-alkyl-11beta-phenylgonanes

SCHERING AG32 citations92
US5273971ADec 28, 1993

13-alkyl-11β-phenylgonanes

SCHERING AG26 citations92
US5244886ASep 14, 1993

11β-phenyl-14βH steroids

SCHERING AG27 citations92
US5095129AMar 10, 1992

19,11 β-bridged steroids, their manufacture and pharmaceutical preparations containing them

SCHERING AG31 citations92
US4829060AMay 9, 1989

11 Beta-N,N-dimethylaminophenyl-estradienes, their manufacture and pharmaceutical preparations containing them

SCHERING AG32 citations92
US4870069ASep 26, 1989

11β-alkynyl-estrenes and -estradienes, their production and pharmaceutical preparations containing them

SCHERING AG27 citations91
US5439913AAug 8, 1995

Contraception method using competitive progesterone antagonists and novel compounds useful therein

SCHERING AG26 citations89
US5426102AJun 20, 1995

14β-H-, 14-and 15-En-11β-aryl-4-oestrenes

SCHERING AG20 citations83
US5132299AJul 21, 1992

11β-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same

SCHERING AG21 citations82
US5446178AAug 29, 1995

Process for preparing 19,11β-bridged steroids

SCHERING AG9 citations74
US5405979AApr 11, 1995

Process for the production of 10β-H-steroids

SCHERING AG15 citations74
US5232915AAug 3, 1993

9α-hydroxy-19,11β-bridged steroids, their production and pharmaceutical preparations containing these steroids

SCHERING AG14 citations74
US6790853B2Sep 14, 2004

Contraception method using competitive progesterone antagonists and novel compounds useful therein

SCHERING AG3 citations73
US6608074B2Aug 19, 2003

Contraception method using competitive progesterone antagonists and novel compounds useful therein

SCHERING AG9 citations73
US6340688B1Jan 22, 2002

Contraception method using competitive progesterone antagonists and novel compounds useful therein

SCHERING AG5 citations73
US5093507AMar 3, 1992

10β,11β-bridged steroids

SCHERING AG15 citations73
US6143733ANov 7, 2000

Quinoxalinedione derivatives, their production and use in pharmaceutical agents

SCHERING AG7 citations72
US5519027AMay 21, 1996

D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents

SCHERING AG5 citations63
US5523298AJun 4, 1996

Progestationally active 19,11-bridged 4-estrenes

SCHERING AG4 citations62
US5359054AOct 25, 1994

Initial compounds for the production of 10β-H-steroids and a process for the production of these initial compounds

SCHERING AG4 citations60
US6596713B1Jul 22, 2003

Steroid esters and amides, process for their production and their pharmaceutical use

SCHERING AG2 citations57
US7321044B2Jan 22, 2008

Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens

SCHERING AG2 citations55
US7297702B2Nov 20, 2007

Contraception method using competitive progesterone antagonists and novel compounds useful therein

SCHERING AG0 citations52
US6096732AAug 1, 2000

Steroid esters, process for their production and their pharmaceutical use

SCHERING AG0 citations52
US5703066ADec 30, 1997

Progestationally active 19,11-bridged 4-estrenes

SCHERING AG1 citations51
US6127368AOct 3, 2000

Anellated β-carbolines

SCHERING AG0 citations39

NOVARTIS AG

3 patents

LAUFFER DAVID

1 patent

SCNERING AG

1 patent

CIS BIO INT

1 patent

SCHERING AKTIIENGESELLSCHAFT

1 patent